The goal of the study is to demonstrate a significant decrease in the rate of Heart Failure (HF) re-hospitalizations based on ReDS-SensiVest™ directed treatment as an adjunct to standard of care during the entire randomized follow-up period.
To learn more about the SMILE Study design please visit ClinicalTrials.gov
allows rEducing readmission rate of heart failure patients
JOIN THE STUDY AS A PATIENT
If you suffer from Heart Failure, please ask your physician about the study.